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Abstract In our previous papers [e.g. Sato et al., J. Biol.
Chem. 273 (1998) 21455^21462], we have shown that prodigio-
sins can uncouple various H+-ATPases through their H+/Cl^
symport activity. BE-18591 is an enamine of 4-methoxy-2,2P-
bipyrrole-5-carboxyaldehyde (tambjamine group antibiotics)
which resembles the prodigiosins. We found that BE-18591
was a new group of antibiotics that uncouples various H+-ATP-
ases: it inhibited proton pump activities with IC50s of about 1^
2 nM (about 20 pmol/mg protein) for submitochondrial particles
as well as gastric vesicles and of 230 nM (about 230 pmol/mg
protein) for lysosomes, but it had little e¡ect on their ATP
hydrolyses (up to 10 WM), a property of H+/Cl^ symport activ-
ity. At low concentrations (6 1 WM), BE-18591 inhibited im-
munoproliferation, the IC50 of lipopolysaccharide-stimulated
mouse splenocytes was 38 nM, that of Concanavalin A-stimu-
lated cells was 230 nM. Gastritis of rabbits was also inhibited.
At higher concentrations (s 1 WM), BE-18591 induced neurite
outgrowth (15% induction in 48 h at 4 WM), inhibited bone
resorption (V35% in 48 h at 10 WM) and caused cell death
(V30% in 48 h at 4 WM) but with little apoptosis. < 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
We have been studying the activity of vacuolar-type Hþ-
ATPase (V-ATPase) inhibitors on cell di¡erentiation (neurite
outgrowth (NOG) of PC12 cells [1] and macrophage produc-
tion from M1 cells [2]), the inhibition of cell growth [3] and
induction of apoptosis in PC12 cells [4]. We have also shown
previously that the prodigiosin group of antibiotics, red pig-
ments produced by microorganisms Streptomyces and Serra-
tia, are a group of Hþ/Cl3 symporters that uncouple various
proton transporters [5^8]. Cycloprodigiosin was able to induce
di¡erentiation and apoptosis in HL60 cells [9]. Recently, BE-
18591 (Fig. 1) was produced by streptomycete strain BA18591
as a yellowish green pigment in the methanol extract [10,11].
It inhibited the growth of some Gram-positive bacteria but
had little e¡ect on those of Gram-negative bacteria and Sac-
charomyces cerevisiae. It also inhibited the growth of P388
cells and MNK human stomach cancer cells in culture, as
well as transplanted Ehrlich ascites tumor cells in BDF1
mice [10]. BE-18591 is regarded as a member of the tambj-
amine group of antibiotics (including tambjamine E and
tambjamine aldehyde) as well as the prodigiosin group [11].
In this paper we report that BE-18591 reversibly uncoupled
various Hþ-ATPases through its Hþ/Cl3 symport activity and
inhibited gastric acid secretion as well as the immune re-
sponses. Furthermore, at higher concentrations, it showed
some degree of inhibition of bone resorption (pit formation),
induction of NOG (in PC12 cells) and cell deaths (apparently
necrosis) in various cells.
2. Materials and methods
2.1. Materials
Rats (Wistar, male) were obtained from Sankyo Labo Service (To-
kyo, Japan). Fluorescein-labeled dextran (FD) was either synthesized
according to [12] or supplied in the form of FITC (£uorescein iso-
thiocyanate)-dextran (MW 70000) from Sigma (St. Louis, MO, USA).
Stomachs of freshly slaughtered hogs were provided by the Meat
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Inspection Center of Kanazawa City (Kanazawa, Japan). Rabbits
(Japan white rabbits, male, 2^2.5 kg in body weight) were obtained
from Shiraishi Laboratory Animal (Tokyo, Japan). BE-18591 was
extracted in methanol from streptomycete strain BA18591and pro-
vided from Tsukuba Research Institute, Banyu Pharmaceutical (Tsu-
kuba, Japan). Prodigiosin 25-C and metacycloprodigiosin were pre-
pared from the culture broth of Streptomyces hiroshimensis as
described elsewhere [13]. Omeprazole was obtained from Fujisawa-
Astra Japan (Osaka). Protease inhibitors of microbial origin were
obtained from the Peptide Research Institute (Osaka). Ba¢lomycin
A1 was kindly provided by Professor K. Altendorf (University of
Osnabru«ck, Osnabru«ck, Germany). 8-Hydroxy-1,3,6-pyrenetrisulfonic
acid, trisodium salt (pyranine), laser grade was from Eastman Kodak
(Rochester, NY, USA). Acridine orange, carbonylcyanide p-tri£uor-
omethoxy-phenylhydrazone (FCCP), 2-[N-morpholino]-ethanesulfonic
acid (MES), N-(2-hydroxy-ethylpiperazine-NP-[2-ethanesulfonic acid)
(HEPES), tetramethylammonium hydroxide (TMAH), sodium gluco-
nate, and glucono-D-lactone were all supplied from Wako (Tokyo,
Japan). Phospholipids were obtained from Sigma (Sigma type II-S
phosphatidylcholine from soybean phospholipids), and used without
puri¢cation. Other reagents were purchased as commercial products
mostly from Sigma (St. Louis, MO, USA) and used without further
puri¢cation.
2.2. Cell culture
Rat pheochromocytoma PC12 cells (RCB 009) were obtained from
the RIKEN Cell Bank (Tsukuba, Japan) and cultured in Dulbecco’s
modi¢ed Eagle’s medium (DMEM, Flow Laboratories) supplemented
with 10% fetal bovine serum (FBS, M.A. Laboratory) 5% horse serum
(COSMO Bio, Japan) and antibiotics (100 U/ml penicillin and 100 Wg/
ml streptomycin) at 37‡C in 5% CO2 and 95% air. CHO-K1 cells were
cultured in F-12 medium (HAM, Nissui, Tokyo, Japan) supplemented
with 0.1% Bactopeptone (Difco Laboratories), 10% FBS and antibi-
otics (as above).
2.3. Preparation of organelles
FD-loaded lysosomes (FD-dextranosomes) were isolated from the
liver of rats injected i.p. with FD 16^20 h earlier according to the
method described elsewhere [14], with the exception that the Percoll
washout procedure was omitted and the lysosomal layer in the Percoll
gradient was used for the experiments. Submitochondrial particles
(SMPs) were prepared from rat liver according to the published pro-
cedure [15,16] before being suspended in the isotonic bu¡er and stored
at 380‡C until use. Membrane vesicles containing (Hþ+Kþ)-ATPase
were mostly puri¢ed from the gastric mucosa of freshly slaughtered
hogs according to [17] with slight modi¢cations [8]. The resulting
pellet was resuspended in 2 ml of 5 mM piperazine-N,NP-(bis-2-etha-
nesulfonic acid) (PIPES)-Tricine (pH 6.8) and stored at 380‡C until
use. The speci¢c activity for the vanadate-sensitive Kþ-ATPase in the
¢nal preparation was about 0.72^075 U/mg protein with little detect-
able ouabain-sensitive ATPase activity.
2.4. Measurement of proton pump activity
The formation of a transmembrane pH gradient (vpH, inside acid)
in lysosomes was measured by the £uorescence quenching of FD in-
corporated into lysosomes [5,18^20]. The formation of vpH in the
vesicles (SMPs and gastric vesicles) was measured by the £uorescence
quenching of a permeant basic dye, acridine orange [6,8]. The assay
bu¡er for lysosomal acidi¢cation contained 0.15 M KCl, 20 mM
HEPES^TMAH (pH 7.5), and 2.5 mM MgCl2 in a ¢nal volume of
2.0 ml. The reaction was started by the addition of 1.0 mM adenosine
triphosphate (ATP)^Na2 [5]. The assay bu¡er for SMPs was 0.15 M
KCl, 20 mM HEPES^TMAH (pH 7.5), 2.5 mM MgCl2 (with or with-
out 1 mM valinomycin) and 1 WM acridine orange in a ¢nal volume of
2.0 ml. The reaction was started by the addition of 2.5 mM ATP^Na2
[6]. The assay bu¡er for gastric vesicles contained 150 mM KCl, 8 mM
PIPES^TMAH (pH 6.8), 2 mM MgCl2, 5 mM valinomycin and 2 WM
acridine orange in a ¢nal volume of 2.0 ml. The reaction was started
by the addition of 1.0 mM ATP^Na2 [8]. Fluorescence was measured
at 37‡C with a Hitachi 850 or F-4500 spectro£uorometer, with com-
binations of excitation at 495 nm and emission at 520 nm for FD and
at 480 nm and 520 nm for acridine orange. The slit widths were 5 nm
for both monochrometers. The initial velocity of acidi¢cation was
de¢ned by the rate of ATP-dependent quenching (vF) of the £uoro-
phores. For the reversibility of BE-18591, the membrane vesicles of
hog gastric mucosa (0.38 mg protein) were preincubated in a total
volume of 100 Wl containing valinomycin with or without the inhib-
itors (10 nM BE-18591) for 3 min at 37‡C. After the preincubation,
1.9 ml of assay medium containing acridine orange, with or without
inhibitors, was added, and the acidi¢cation of these membrane
vesicles was started by the addition of 1.0 mM ATP. The change in
£uorescence was traced with the excitation at 493 nm and emission at
530 nm.
2.5. Measurement of ATPase activity
The assay bu¡er for lysosomal V-ATPase (ba¢lomycin A1-sensitive
ATPase) contained 0.15 M KCl, 20 mM HEPES^TMAH (pH 7.5),
2.5 mM MgCl2, and 2.5 mM ATP^Na2 in a ¢nal volume of 1.0 ml.
The samples were incubated at 37‡C for 40 min [21]. The assay bu¡er
for SMP contained 0.15 M KCl, 20 mM HEPES^TMAH (pH 7.5),
2.5 mM MgCl2, and 2.5 mM ATP^Na2 in a ¢nal volume of 1.0 ml.
The incubation temperature and period were 37‡C and 40 min, re-
spectively [6]. The assay bu¡er for gastric mucosa membranes con-
tained 150 mM KCl, 8 mM PIPES^TMAH (pH 6.8), 2 mM MgCl2,
5 mM valinomycin, 1.0 mM ATP^Na2, and 5 Wg/ml of protease in-
hibitors (leupeptin, antipain, chymostatin, and pepstatin), in a ¢nal
volume of 1.0 ml. The negative control bu¡er contained 150 mM
choline chloride instead of KCl. Assays were started by adding mem-
brane vesicles (about 2.38 mg gastric mucosa protein/tube) and the
samples incubated at 37‡C for 10 min [8,17]. The liberated phosphate
was estimated by the malachite green method [22].
2.6. Estimation of H+/Cl^ symport activity using liposomes
Hþ/Cl3 symport activity was measured by the £uorescence quench-
ing of pH-sensitive pyranine incorporated into liposomes and osmotic
swelling of liposomes in ammonium chloride-containing medium [7].
Liposomes were prepared from phosphatidylcholine (Sigma type II-S
phospholipids, so-called asolectin) essentially as described elsewhere
[7]. Brie£y, phosphatidylcholine was suspended at 50 mg/ml in a
20 mM HEPES^TMAH (pH 7.5) bu¡er containing 25 mM of gluco-
nate (usually 2 ml). The mixture was vortexed vigorously and soni¢ed
to clarity at room temperature for 5 min. It was then applied onto a
spin column equilibrated with the assay bu¡er and centrifuged at
2000 rpm for 30 s just before use. The swelling of liposomes in hyper-
tonic ammonium salts was monitored by the decrease in absorbance
at 550 nm [23]. Liposomes prepared in 2 mM HEPES^TMAH (pH
7.5), and 0.25 M sucrose were loaded in 0.2 M ammonium salt of the
anion (e.g. NH4Cl, NH4-gluconate), and then after 30 s the BE-18591
was added while the OD550 was monitored.
2.7. Immunosuppression
Immunosuppressive activity was assessed by the growth inhibition
of stimulated mouse spleen lymphocytes [24]. Brie£y, in the mitogenic
response, mice splenocyte (5U105 cells/well, 200 Wl) were plated in a
£at-bottom microtiter plate in triplicate cultures. Cells were cultured
for 48 h either with 2 Wg/ml lipopolysaccharide (LPS) or with 1 Wg/ml
concanavalin A (Con A). [3H]Thymidine (9.23 kBq/well) was added to
each well 4 h before harvesting. The cells were harvested on a glass
¢lter and the radioactivity was measured by a liquid scintillation
counter.
2.8. Fluorescent measurement of cell growth, cell viability and
chromosome condensation
Cell growth was estimated essentially according to [3]. The £uores-
cence was measured using a £uorescence spectrophotometer (Hitachi
model F-4500, VEx = 356 nm, VEm =458 nm). Cell viability was ac-
cessed by dual £uorescence staining with propidium iodide and £uo-
rescein-diacetate (FDA) [25]. Cells plated in 24-well culture dishes
were incubated in a medium containing propidium iodide (50 nM)
and FDA (0.15 nM) at 37‡C for 10 min, before being washed and
observed by epi£uorescence microscopy (Olympus, BH2-RFK or
IMT-2-21CA3 with B-excitation). The viable cells £uoresced green
due to the £uorescein accumulated through the cytoplasmic hydrolysis
of FDA, while the nuclei of dead cells £uoresced red because of the
propidium iodide taken up due to loss of the permeability barrier.
Apoptosis was accessed morphologically as chromatin condensation
by staining mostly with Hoechst 33258 (or 33342) after the cells had
been ¢xed with 2% glutaraldehyde and washed once with DMEM by
centrifugation (3000Ug for 5 min) [4].
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2.9. Gastric secretion
Parietal cells of rabbit gastric glands were isolated essentially as
described previously [26]. Parietal cells were isolated from the gastric
gland by combined collagenase digestion [27] and Percoll density gra-
dient cell fractionation methods [28], with slight modi¢cations [8]. A
primary culture of isolated parietal cells was performed according to
the method of Chew et al. [29] with slight modi¢cations [8]. The
isolated parietal cells were cultured on glass coverslips coated with
collagen type IV in a medium consisting of DMEM plus 10% FBS
at 37‡C in a humidi¢ed atmosphere of 5% CO2 and 95% air. The acid
secretion was essentially as described elsewhere [30] using the accu-
mulation of the £uorescent weak base, acridine orange, in apical vac-
uoles. Cells were preincubated in a medium containing 5 WM acridine
orange, before being stimulated with histamine (1034 M). They were
then further incubated for 40 min and viewed under a phase-contrast
£uorescent microscope (Axiovert+35M, Zeiss) using a B-type dichroic
mirror (excitation ¢lter, BP450^490; dichroic mirror, FT510; barrier
¢lter, LP520) [8].
2.10. NOG of PC12 cells
NOG of PC12 cells was estimated as described previously [1]. A
neurite was de¢ned as a process whose length was more than 1.5 times
longer than that of the cell body as judged from the photographs
taken under phase contrast microscopy (Olympus, Tokyo). About
150 cells were counted per well, and the percentage of cells with
neurites was calculated.
2.11. Pit assay for bone-resorbing activity
To determine the bone-resorbing activity, we measured the area and
number of resorption pits formed on dentine slices by isolated mature
osteoclasts [31,32]. The concentrations of parathyroid hormone and
vitamin D3 were both 10 WM.
2.12. Other analytical methods
Protein was determined by the amido black/solid phase method
[33], or with the Coomassie brilliant blue/liquid phase method [34]
using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, USA),
with BSA as the standard.
3. Results
3.1. E¡ect of BE-18591 on the proton pump and ATPase
activities of V-, F-, and P-ATPases
Proton pump activities of V-, F- and P-ATPase were inhib-
ited by prodigiosins (prodigiosin 25-C, metacycloprodigiosin
and prodigiosin) at relatively low concentrations [5^8]. The
e¡ect of BE-18591 on the proton pump activity was ¢rst in-
vestigated in this study. As shown in Fig. 2, it inhibited the
proton pump activity of the lysosomal proton pump (V-ATP-
ase) with an IC50 of 80 nM (about 230 pmol/mg protein)
(350 Wg protein/ml). It also inhibited the mitochondrial
ATP-dependent proton pump activity (F-ATPase) with an
IC50 of 1 nM (about 10 pmol/mg protein) (100 Wg protein),
as well as the ATP-dependent proton pump activity (P-ATP-
ase) of rabbit gastric mucosa with an IC50 of 2 nM (100 Wg
protein) (about 20 pmol/mg protein). Furthermore, the proton
pump inhibiting activity was reversible for P-type proton
pumps as shown in Fig. 3. The proton pump activity of gas-
Fig. 1. Chemical structure of BE-18591. BE-18591 used was the hy-
drochloric acid salt (C22H35N3OWHCl) and its molecular weight was
approximately 393.5.
Fig. 2. E¡ect of BE-18591 on the acidi¢cation activity of various
Hþ-ATPases. Preparations of subcellular organelles and assay meth-
ods of the proton pump activity were performed according to Sec-
tion 2. a, rat liver submitochondrial Hþ-ATPase; b, rat liver lyso-
somal Hþ-ATPase; E, hog gastric membrane vesicle (Hþ/Kþ)-
ATPase; Control, 1% dimethyl sulfoxide (DMSO, solvent of BE-
18591).
Fig. 3. Reversibility of BE-18591 on the acidi¢cation of hog gastric
membrane vesicles. Preparations of hog gastric membrane vesicles
and the reversibility of the proton pump activity were performed ac-
cording to Section 2. The ¢nal concentration of BE-18591 pre-incu-
bated at 10 nM was 0.5 nM in the proton pump assay medium.
H2O, distilled water instead of ATP; DMSO, 1%; FCCP, 1 mM
(ethanol was less than 1%); TX-100, 0.1% Triton X-100.
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tric membrane vesicle inhibited by 10 nM BE-18591 was re-
versed after a 20-fold dilution (¢nal BE-18591 was 0.5 nM)
with medium. Essentially similar results were obtained with
other types of ATPases. However, BE-18591 inhibited ATP
hydrolysis only at higher concentrations with an IC50 of about
400 nM (about 160 nmol/mg protein) (2.5 Wg protein/ml) for
ATP hydrolysis by hog gastric mucosa membrane vesicle P-
ATPase. A similar uncoupling tendency has been observed
with other types of ATPases. These results indicate that BE-
18591 is a non-speci¢c inhibitor against various types of Hþ
pump.
3.2. H+/Cl^ symport activity
The inhibitions of the proton pump activities by BE-18591
were all prevented by a large amount of liposomes (data not
shown), suggesting that they were related to the non-speci¢c
lipid solubility of BE-18591. Therefore, its e¡ect on the lipo-
somes themselves was observed. BE-18591 induced acidi¢ca-
tion of the intraliposomal pH by the addition of chloride, and
this was further accelerated by the addition of acidic bu¡er,
both in a chloride concentration dependent manner (Fig. 4).
On the other hand, BE-18591 did not produce intraliposomal
acidi¢cation upon the addition of an anion gradient or by the
addition of acidic bu¡er when the anion was gluconate (mem-
brane-impermeant) (¢gure not shown). However, BE-18591
did cause swelling of liposomes in the presence of chloride
anion (ammonium chloride, ¢gure not shown). These results
suggest that BE-18591 inhibited the ATP-dependent Hþ-
pump activities through its Hþ/Cl3 symport (functionally
equal to Hþ/OH3 antiport) activity.
3.3. Immunosuppression
Prodigiosins have been shown to inhibit lymphocyte prolif-
erations [29]. BE-18591 also inhibited the proliferation of
mouse spleen lymphocytes as shown in Fig. 5. However, the
concentration of BE-18591 required for the inhibition of the
growth of mouse splenocytes was one order higher than that
of prodigiosin 25-C. Furthermore, the speci¢city of BE-18591
for LPS (speci¢c B-cell mitogen) rather than Con A (speci¢c
T-cell mitogen) was less than that of prodigiosin 25-C. Thus,
the IC50 of BE-18591 against LPS-stimulated splenocytes was
38 nM and against Con A-stimulated cells 230 nM, while the
IC50 of prodigiosin 25-C against LPS-stimulated cells was
0.95 nM and against Con A-stimulated cells 21.45 nM. These
results suggest that BE-18591 was weaker and less speci¢c to
lymphocyte mitogens than prodigiosin 25-C.
3.4. Growth inhibition
BE-18591 inhibited the growth of mouse spleen cells (see
above) and CHO cells (IC50 = 200^300 nM, ¢gure not shown).
However, BE-18591 had little a¡ect on the growth of PC12
cells (IC50 s 10 WM). This suggests that PC12 cells were rel-
atively resistant to BE-18591. BE-18591 seemed to inhibit the
growth of mouse splenocytes and CHO cells through its cy-
totoxic rather than cytostatic e¡ect, because the dose-re-
sponses were similar. However, BE-18591 did not cause apo-
ptosis as the cells died from necrosis (¢gure not shown). This
is in contrast to the apoptotic e¡ects of ba¢lomycins and
prodigiosins [4,24].
3.5. Inhibition of gastric acid secretion
Prodigiosins have been shown to inhibit rabbit gastritis by
inhibiting apical vacuole acidi¢cation of parietal cells from
rabbit gastric mucosa [8]. BE-18591 also inhibited rabbit gas-
tritis by inhibiting apical vacuole acidi¢cation of parietal cells
from rabbit gastric mucosa as observed by quinacrine £uores-
cence (Fig. 6). BE-18591 inhibited the orange £uorescence of
quinacrine more strongly than omeprazole or prodigiosin 25-
C, suggesting that BE-18591 was the most potent among these
substances at inhibiting gastritis.
3.6. Induction of NOG
Prodigiosins as well as ba¢lomycins have been shown to
induce cell di¡erentiation in a dose-dependent manner [1,9].
BE-18591 also induced NOG of PC12 cells but only at higher
concentrations (s 100 nM) and weakly (6 15%).
Fig. 5. Immunosuppressive activities of BE-18591. Blastogeneses of
mouse splenocytes were performed according to Section 2. Concen-
trations of LPS and Con A were 2 Wg/ml and 1 Wg/ml, respectively.
IC50s of prodigiosin 25-C were 0.4 ng/ml for Con A-stimulated and
9 ng/ml for LPS-stimulated mouse splenocytes, and those of BE-
18591 were 15 ng/ml and 90 ng/ml, respectively. All the data shown
are the averaged results (meanWS.D.). [3H]TdR, [3H]thymidine;
A: prodigiosin 25-C; B: BE-18591; a, LPS-stimulated mouse sple-
nocytes; z.cirf ;, Con A-stimulated mouse splenocytes.
Fig. 4. Hþ/Cl3 symport activity of BE-18591 as revealed by the use
of liposomes. Liposomes containing pyranine, prepared in a bu¡er
(20 mM HEPES^TMAH, pH 7.5) containing either K-gluconate
(25 mM K-gluconate, 2.5 mM MgSO4) were diluted 40-fold in ex-
ternal bu¡er (20 mM HEPES^TMAH, pH 7.5) containing 25 mM
NaCl. At the times indicated, BE-18591 (1 nM^1 WM) was added to
decrease intraliposomal pH and this was followed by a further rapid
and signi¢cant decrease in the intraliposomal pH by 50 mM MES^
TMAH (pH 6.0). MES^TMAH, 50 mM MES^TMAH (pH 6.0);
TX-100, 0.2% Triton X-100; BE-18591, 1 nM^1 WM.
FEBS 26286 17-7-02 Cyaan Magenta Geel Zwart
K. Tanigaki et al./FEBS Letters 524 (2002) 37^4240
3.7. Inhibition of bone resorption
Prodigiosin 25-C and metacycloprodigiosin have been re-
ported to suppress the bone resorption by rat osteoclasts
[35]. BE-18591 also inhibited bone resorption in a dose-depen-
dent manner in the presence of 10 WM parathyroid hormone
and 1,25-vitamin D3. However, its bone resorbing activity
(70% at 10 WM BE-18591) was evidently less than that of
calcitonin (A20% at 1036 M) (¢gure not shown). This suggests
that the bone-resorbing activity of BE-18591 is limited.
4. Discussion
BE-18591 is regarded as a member of both the tambjamine
group of antibiotics as well as the prodigiosin group [11]. The
tambjamine group of antibiotics were ¢rst isolated from the
ascidian Atapozoa sp. and its nudibranch predators [36]. In
this paper, we have shown that BE-18591 (1) inhibited various
ATP-dependent proton pumps, (2) showed Hþ/Cl3 symport
activity on liposomes, (3) inhibited acid secretion by rabbit
gastric parietal cells, and (4) inhibited the mitogenic response
of mouse splenocytes (and growth of CHO cells). Therefore,
BE-18591 is similar to prodigiosins in both structure and ac-
tivity [8,11]. In fact, we also observed the inhibition of Heli-
cobacter pylori [NCTC 11637] growth by BE-18591 (MIC
[minimum inhibitory concentration] = 0.5 Wg/ml [37]). Cyclo-
prodigiosin induced both cell di¡erentiation and apoptosis in
HL60 cells [9]. BE-18591 also induced NOG in PC12 cells in a
dose dependent manner, but its e¡ect was weaker than that of
prodigiosins (data not shown). BE-18591 also induced growth
inhibition and cell death in a dose dependent manner in
mouse splenocytes, CHO cells, P388 cells (IC50 = 0.258 Wg/ml
[V724 nM]) and MNK human stomach cancer cells
(IC50 = 0.52 Wg/ml [V1.320 WM]) [9]. However, the growth
inhibiting e¡ect was weaker than the prodigiosins and it had
little a¡ect on the growth of PC12 cells. Furthermore, BE-
18591 did not cause apoptosis, as the cells probably died
through necrosis. These results suggest that BE-18591 inhib-
ited cell growth because it induced cell death, and it is some-
how speci¢c to cells. In vivo, BE-18591 has been reported to
have anti-tumor e¡ects on Ehrlich tumor cells but not on
P388 leukemia cells (both ascites types) in BDF1 mice [10].
The NOG-inducing activity of BE-18591 is probably be
caused by a mechanism other than apoptosis. In fact, tetra-
pyrrole [38,39], an analogue of 4-methoxy-2,2P-bipyrrole-5-
pyrromethene, strongly induced apoptosis but induced little
NOG (data not shown).
The mechanism of growth inhibition by BE-18591 remains
unclear. There is a paper insisting that its copper-nuclease
activity correlated well with its death inducing e¡ect [40,41].
However, its Hþ/Cl3 activity also showed a good correlation
with death-inducing activity. 4-Methoxy-2,2P-bipyrrole-5-car-
boxyaldehyde (also called tambjamine aldehyde), a precursor
of BE-18591, neither inhibited the proton pump nor ATP
hydrolysis activities of the P-ATPase in hog gastric mucosa
membrane vesicles (data not shown). These results suggest
that at least three nitrogens, among which two should be in
pyrrole rings, are required for the Hþ/Cl3 symport activity in
this type of compound. These results also indicate that the
correlation itself does not explain the mechanisms. However,
Hþ/Cl3 symport activity does not seem to be restricted to this
type of compound; other types of Hþ/Cl3 symporters (TlCl3
[42], Bepridil [43], Hg2þ and Cuþ [44]) have completely di¡er-
ent structures. Furthermore, pamamycin [45] and cryptate [46]
(both completely di¡erent from tambjamines) might be candi-
Fig. 6. Inhibition of acid secretions. Parietal cells isolated from rabbit gastric glands were preincubated in medium containing 5 WM acridine or-
ange, and then stimulated with histamine (1034 M) before being further incubated for 40 min in the presence or absence of inhibitors (omepra-
zole, prodigiosin 25-C or BE-18591 with DMSO as the solvent control). The cells were viewed under a phase contrast £uorescent microscope
(B-type dichroic mirror). A: control (1% DMSO). B: 100 WM omeprazole. C: 2.5 WM prodigiosin 25-C. D: 1 WM BE-18591. Bar represents
50 Wm. Accumulation of orange £uorescence in the large vacuoles disappeared after treatment of parietal cells with prodigiosin 25-C, and BE-
18591 as well as with omeprazole.
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dates for other types of Hþ/Cl3 symporters. These com-
pounds did not show a correlation between the inhibition of
cell growth and the Hþ/Cl3 symport activity. At present we
do not have any data on the copper-nuclease activity of these
compounds or BE-18591. PNU156804, a prodigiosin 25-C
analogue, has been shown to a¡ect cellular JAK kinase 3
[47]. A similar e¡ect might be related to the growth inhibition
by BE-18591. Further studies are necessary to clarify the pre-
cise mechanism through which BE-18591 acts.
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